Abstract
T combination of phentermine and fenfluramine hydrochloride is widely used for the treatment of exogenous obesity even though there has been only 1 full published study.<sup>1</sup>The therapy is cheap, highly successful, and well tolerated. Nevertheless, experience in Europe suggests that there is a grave risk of primary pulmonary hypertension (PPH) from fenfluramine, whether dispensed as the racemic mixture or the pure D-isomer.<sup>2</sup>Even though the risk for PPH is small, the mortality is high, the results of treatment are uncertain, and there is no proven screening method. I have treated 557 patients with a variation of the "phen-fen" combination, in which fenfluramine was replaced with fluoxetine hydrochloride. The chemical structure of fluoxetine is similar to that of fenfluramine; both drugs are serotonin-promoting agents, and fluoxetine acts on the cerebral appestat as well as fenfluramine. My patients have lost 3645 kg in 2 years. Only 7 patients failed
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
